CTI BioPharma
CTIC
#5622
Rank
$1.19 B
Marketcap
$9.09
Share price
0.00%
Change (1 day)
30.79%
Change (1 year)

Earnings for CTI BioPharma (CTIC)

Earnings in 2023 (TTM): -$69.24 Million USD

According to CTI BioPharma 's latest financial reports the company's current earnings are $75.76 Million USD. In 2022 the company made an earning of -$93 Million USD, an increase over its 2021 earnings that were of -$97.91 Million USD. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for CTI BioPharma from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -$69.24 Million-25.54%
2022 -$93 Million-5.02%
2021 -$97.91 Million86.67%
2020 -$52.46 Million31.05%
2019 -$40.03 Million36.36%
2018 -$29.36 Million-28.11%
2017 -$40.84 Million-22.89%
2016 -$52.96 Million-56.15%
2015 -$0.13 Billion28.16%
2014 -$94.23 Million116.37%
2013 -$43.55 Million-57.17%
2012 -$0.11 Billion62.39%
2011 -$62.62 Million-16.23%
2010 -$74.76 Million-20.68%
2009 -$94.25 Million22.01%
2008 -$77.25 Million-28.59%
2007 -$0.11 Billion10.34%
2006 -$98.03 Million118.07%
2005 -$44.96 Million-70.71%
2004 -$0.16 Billion25.18%
2003 -$0.13 Billion21.81%
2002 -$0.11 Billion20.55%
2001 -$83.49 Million50.36%
2000 -$55.53 Million49.26%
1999 -$37.2 Million35.27%
1998 -$27.5 Million7%
1997 -$25.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
$8.24 B-12,006.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$8.03 B-11,701.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
$1.58 B-2,393.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-$0.27 Billion 289.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$22.50 B-32,601.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$1.77 B-2,659.25%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
$16.41 B-23,813.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland